Csf1+ AD-MSCs promote stroke repair by activating the resident microglia
Experimental Biology and Medicine · 2025
DOI: 10.3389/ebm.2025.10611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2025. Verfasst von Jiguang Hou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Microglia, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Macrophage Colony-Stimulating Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Sichuan Province.
Themen: Schlaganfall
Abstract (Originalsprache)
The potential of mesenchymal stromal cells (MSCs) in the treatment of hemorrhagic stroke has been demonstrated; however, their clinical efficacy remains inconsistent and further comprehensive studies on their mechanism of action are warranted. In this study, the intracerebral hemorrhage (ICH) rat model was used for intravenous infusion of adipose-derived mesenchymal stromal cells (AD-MSCs) 24 h after modeling. Histopathological techniques and single cell transcriptome sequencing techniques were used to study the mechanism of AD-MSCs promoting the repair of damaged brain tissue. The results indicated that AD-MSCs markedly promote the repair of damaged brain tissues and restored neural function. Single-cell transcriptome sequencing further revealed that this therapeutic effect is specifically through the inhibition of monocyte infiltration in injured brain tissue, promotion of resident microglia proliferation and signaling pathways linked to immune response and neuroprotection. These processes are closely tied to the Csf1 + subgroup of AD-MSCs. For acute hemorrhagic stroke, Csf1 + AD-MSCs promote the repair of damaged brain tissue by activating resident microglia and inhibiting monocyte infiltration. This study offers novel insights into the mechanisms underlying MSC-based stroke treatment and supports the potential for stable and efficacious MSC therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, China.
- Department of Neurosurgery, Third People's Hospital of Chengdu, Chengdu, China.
- Department of Neurosurgery, Fifth People's Hospital of Chengdu, Chengdu, China.
- Tasly Stem Cell Biology Laboratory, Tasly Group, Tianjin, China.
- Regenerative Medicine Research Center, West China Hospital of Sichuan University, Chengdu, China.
Förderung
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Hou, J., Zhang, S., Luo, S., Zuo, X., Ma, F., Wang, H., Han, P., Zhu, P., Wang, N., Hou, X., & Li, J. (2025). Csf1+ AD-MSCs promote stroke repair by activating the resident microglia. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2025.10611
Vancouver
Hou J, Zhang S, Luo S, Zuo X, Ma F, Wang H, et al. Csf1+ AD-MSCs promote stroke repair by activating the resident microglia. Experimental Biology and Medicine. 2025. doi:10.3389/ebm.2025.10611
BibTeX
@article{Hou2025,
author = {Hou, Jiguang and Zhang, Sunfu and Luo, Shuang and Zuo, Xiao and Ma, Fei and Wang, Huizhen and Han, Pengfei and Zhu, Ping and Wang, Ning and Hou, Xiaoming and Li, Jin},
title = {Csf1+ AD-MSCs promote stroke repair by activating the resident microglia},
journal = {Experimental Biology and Medicine},
year = {2025},
doi = {10.3389/ebm.2025.10611}
}
EUVIMED